3-D Ultrasound IDs Late-Onset Fetal Growth Restriction

This article originally appeared here.
Share this content:
3-D Ultrasound IDs Late-Onset Fetal Growth Restriction
3-D Ultrasound IDs Late-Onset Fetal Growth Restriction

MONDAY, Oct. 9, 2017 (HealthDay News) -- Fractional thigh volume measurements improve detection of late-onset fetal growth restriction, compared to two-dimensional biometry, according to a study published in the October issue of the American Journal of Obstetrics & Gynecology.

Louise E. Simcox, M.B.Ch.B., from the University of Manchester in the United Kingdom, and colleagues derived normal values for three-dimensional fractional thigh volume in the third trimester. Prospectively, the authors evaluated 115 unselected pregnancies using both standard two-dimensional ultrasound biometry measurements and fractional thigh volume measurements.

The researchers observed a better correlation between fractional thigh volume and estimated fetal weight obtained at 34 to 36 weeks with birth weight, compared to two-dimensional biometry measures such as abdominal circumference and estimated fetal weight. Fractional thigh volume-derived measurements also modestly improved detection of both small for gestational age and fetal growth restriction, compared to standard two-dimensional measurements (area under receiver operating characteristic curve, 0.86 and 0.92, respectively).

"Fractional thigh volume measurements offer some improvement over two-dimensional biometry for the detection of late-onset fetal growth restriction at 34 to 36 weeks," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Extended-Release Naltrexone Promising for Opioid Dependence

Extended-Release Naltrexone Promising for Opioid Dependence

Lower use of heroin, other illicit opioids with extended-release naltrexone in superiority analysis

New Expert Consensus Pathway for Mitral Regurgitation

New Expert Consensus Pathway for Mitral Regurgitation

Etiology, mechanism, severity, indications for treatment should be assessed after MR is identified

Many Dermatology Guideline Authors Get Industry Payments

Many Dermatology Guideline Authors Get Industry Payments

22 of 40 guideline authors receiving payments did not accurately disclose industry relationships

is free, fast, and customized just for you!

Already a member?

Sign In Now »